Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × rezivertinib × Thoracic × Clear all

Phase

Status

Completed 2 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 60 Cisplatin 42 Pemetrexed 37 Drug Therapy 35 osimertinib 22 anlotinib 22 Etoposide 20 Surgical Procedures, Operative 17 Paclitaxel 17 pembrolizumab 16 tislelizumab 15 toripalimab 14 Radiotherapy 14 130-nm albumin-bound paclitaxel 14 aflutinib 12 Docetaxel 11 Bevacizumab 11 sintilimab 10 Injections 10 durvalumab 9 Specimen Handling 9 Platinum 8 Magnetic Resonance Spectroscopy 8 Immunotherapy 8 cemiplimab 7 atezolizumab 7 Radiosurgery 7 Platinum Compounds 7 PM 01183 7 lorlatinib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06955325 2025-05-06

UPLIFT

The First Affiliated Hospital of Guangzhou Medical University

Phase 3 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡